BIOMAT Database Logo BIOMAT Database Logo

Novel chiral skeletons for drug discovery: antibacterial tetramic acids. 2011

Chloe A Holloway, and Christopher J Matthews, and Yong-Chul Jeong, and Mark G Moloney, and Christine F Roberts, and Muhammad Yaqoob
Department of Chemistry, Chemistry Research Laboratory, University of Oxford, 12 Mansfield Road, Oxford OX1 3TA, UK.

Modification of the ring nucleus of tetramic acids derived from serine gives chiral heterocyclic libraries that exhibit antibacterial activity, and correlation with various physicochemical parameters indicates that chiral tetramic acids may provide a potentially valuable non-aromatic skeleton for fragment-based drug discovery.

UI MeSH Term Description Entries
D011760 Pyrrolidinones A group of compounds that are derivatives of oxo-pyrrolidines. A member of this group is 2-oxo pyrrolidine, which is an intermediate in the manufacture of polyvinylpyrrolidone. (From Merck Index, 11th ed) Pyrrolidinone,Pyrrolidone,Pyrrolidones
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D013237 Stereoisomerism The phenomenon whereby compounds whose molecules have the same number and kind of atoms and the same atomic arrangement, but differ in their spatial relationships. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Molecular Stereochemistry,Stereoisomers,Stereochemistry, Molecular,Stereoisomer
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D055808 Drug Discovery The process of finding chemicals for potential therapeutic use. Drug Prospecting,Discovery, Drug,Prospecting, Drug
D040141 Staphylococcaceae Family of gram-positive, facultatively anaerobic bacteria, in the order Bacillales. Genera include Gemella, Macrococcus, Salinicoccus, and STAPHYLOCOCCUS.

Related Publications

Chloe A Holloway, and Christopher J Matthews, and Yong-Chul Jeong, and Mark G Moloney, and Christine F Roberts, and Muhammad Yaqoob
Aromatic dienoyl tetramic acids. Novel antibacterial agents with activity against anaerobes and staphylococci.
May 1989, Journal of medicinal chemistry,
Chloe A Holloway, and Christopher J Matthews, and Yong-Chul Jeong, and Mark G Moloney, and Christine F Roberts, and Muhammad Yaqoob
Antisense peptide nucleic acids in antibacterial drug discovery.
October 2004, Molecular therapy : the journal of the American Society of Gene Therapy,
Chloe A Holloway, and Christopher J Matthews, and Yong-Chul Jeong, and Mark G Moloney, and Christine F Roberts, and Muhammad Yaqoob
Innovative approaches to novel antibacterial drug discovery.
December 1997, Current opinion in biotechnology,
Chloe A Holloway, and Christopher J Matthews, and Yong-Chul Jeong, and Mark G Moloney, and Christine F Roberts, and Muhammad Yaqoob
Synthesis and antibacterial activity of monocyclic 3-carboxamide tetramic acids.
January 2013, Beilstein journal of organic chemistry,
Chloe A Holloway, and Christopher J Matthews, and Yong-Chul Jeong, and Mark G Moloney, and Christine F Roberts, and Muhammad Yaqoob
Targeting Helicobacter pylori for antibacterial drug discovery with novel therapeutics.
December 2022, Current opinion in microbiology,
Chloe A Holloway, and Christopher J Matthews, and Yong-Chul Jeong, and Mark G Moloney, and Christine F Roberts, and Muhammad Yaqoob
Designing chiral libraries for drug discovery.
August 2000, Drug discovery today,
Chloe A Holloway, and Christopher J Matthews, and Yong-Chul Jeong, and Mark G Moloney, and Christine F Roberts, and Muhammad Yaqoob
Antitumor, cytotoxic, and antibacterial activities of tenuazonic acid and congeneric tetramic acids.
July 1965, Journal of medicinal chemistry,
Chloe A Holloway, and Christopher J Matthews, and Yong-Chul Jeong, and Mark G Moloney, and Christine F Roberts, and Muhammad Yaqoob
Genetic strategies for antibacterial drug discovery.
June 2003, Nature reviews. Genetics,
Chloe A Holloway, and Christopher J Matthews, and Yong-Chul Jeong, and Mark G Moloney, and Christine F Roberts, and Muhammad Yaqoob
Whither antibacterial drug discovery?
April 2008, Drug discovery today,
Chloe A Holloway, and Christopher J Matthews, and Yong-Chul Jeong, and Mark G Moloney, and Christine F Roberts, and Muhammad Yaqoob
Antibacterial Mimics of Natural Products by Side-Chain Functionalization of Bicyclic Tetramic Acids.
September 2018, The Journal of organic chemistry,
Copied contents to your clipboard!